Mucopolysaccharidosis type VI
Other Names for this Disease
- MPS VI
- Mucopolysaccharidosis type 6
- MPS 6
- Arylsulfatase B deficiency
- ARSB deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Mucopolysaccharidosis type VI. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|Generic Name||N-acetylgalactosamine-4-sulfatase, recombinant human|
(BioMarin Pharmaceutical, Inc.)
The FDA has approved this product to be used in this manner.
|For patients with mucopolysaccharidosis VI. Galsulfase has been shown to improve walking and stair-climbing capacity.|
|More Information about this product||Drug Information Portal|